Kento Fukano

550 total citations
19 papers, 397 citations indexed

About

Kento Fukano is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, Kento Fukano has authored 19 papers receiving a total of 397 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Epidemiology, 14 papers in Hepatology and 4 papers in Infectious Diseases. Recurrent topics in Kento Fukano's work include Hepatitis B Virus Studies (15 papers), Hepatitis C virus research (14 papers) and Liver Disease Diagnosis and Treatment (6 papers). Kento Fukano is often cited by papers focused on Hepatitis B Virus Studies (15 papers), Hepatitis C virus research (14 papers) and Liver Disease Diagnosis and Treatment (6 papers). Kento Fukano collaborates with scholars based in Japan, France and United States. Kento Fukano's co-authors include Koichi Watashi, Takaji Wakita, Senko Tsukuda, Camille Sureau, Masamichi Muramatsu, Yuki Ogasawara, Hideki Aizaki, Sam‐Yong Park, Yasuhito Tanaka and Masashi Mizokami and has published in prestigious journals such as Journal of Virology, Scientific Reports and Biochemical and Biophysical Research Communications.

In The Last Decade

Kento Fukano

18 papers receiving 394 citations

Peers

Countries citing papers authored by Kento Fukano

Since Specialization

Citations

This map shows the geographic impact of Kento Fukano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kento Fukano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kento Fukano more than expected).

Fields of papers citing papers by Kento Fukano

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kento Fukano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kento Fukano. The network helps show where Kento Fukano may publish in the future.

Co-authorship network of co-authors of Kento Fukano

This figure shows the co-authorship network connecting the top 25 collaborators of Kento Fukano. A scholar is included among the top collaborators of Kento Fukano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kento Fukano. Kento Fukano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work	Indexed citations
1	RXR agonist S169 inhibits HBV/HDV entry in vitro by disrupting KIF4-dependent NTCP trafficking 2025 ·Antiviral Research ·(unknown), (unknown), (unknown), Kento Fukano, Takanobu Kato, Ikuo Shoji, Kazuaki Chayama, Masamichi Muramatsu, Masanori Isogawa, Takaji Wakita, Daniel Merk, Hussein Hassan Aly	1
2	Large-scale screening of SARS-CoV-2 variants in Tokyo, Japan: A 3-year and 9-month longitudinal survey 2025 ·Global Health & Medicine ·Junko S. Takeuchi, Kei Yamamoto, MASAMI KUROKAWA, Kento Fukano, (unknown), Etsuro Hatano, (unknown), (unknown), Yuki Takamatsu, Hiroaki Mitsuya, Norio Ohmagari, Moto Kimura, Wataru Sugiura	0
3	Selective inhibition of hepatitis B virus internalization by oxysterol derivatives 2023 ·Biochemical and Biophysical Research Communications ·(unknown), Frank Stappenbeck, Hirofumi Ohashi, Masashi Iwamoto, Kento Fukano, (unknown), (unknown), (unknown), Ryo Morishita, Hideki Aizaki, Ryosuke Suzuki, Masamichi Muramatsu, Kouji Kuramochi, Camille Sureau, Farhad Parhami, Koichi Watashi	3
4	Amentoflavone inhibits hepatitis B virus infection via the suppression of preS1 binding to host cells 2023 ·Microbiology and Immunology ·(unknown), (unknown), Kento Fukano, Masamichi Muramatsu, Nina Artanti, Muhammad Hanafi, Hak Hotta, Masanori Kameoka	6
5	A versatile method to profile hepatitis B virus DNA integration 2023 ·Hepatology Communications ·Kento Fukano, Kousho Wakae, Naganori Nao, Masumichi Saito, Akihito Tsubota, (unknown), Hideki Aizaki, Hiroko Iijima, (unknown), Moto Kimura, Koichi Watashi, Wataru Sugiura, Masamichi Muramatsu	1
6	Identification of neutralizing epitopes in the preS2 domain of the hepatitis B virus 2022 ·Virus Research ·(unknown), Mami Matsuda, Kento Fukano, Tomohisa Tanaka, Kohji Moriishi, Hironori Nishitsuji, Kunitada Shimotohno, Koji Tamura, Takaji Wakita, Masamichi Muramatsu, Takanobu Kato, Ryosuke Suzuki	4
7	The kinesin KIF4 mediates HBV/HDV entry through the regulation of surface NTCP localization and can be targeted by RXR agonists in vitro 2022 ·PLoS Pathogens ·(unknown), Masaya Sugiyama, Masataka Tsuge, (unknown), Kento Fukano, (unknown), Camille Sureau, Noriyuki Watanabe, Takanobu Kato, Asako Murayama, Yingfang Li, Ikuo Shoji, Kunitada Shimotohno, Kazuaki Chayama, Masamichi Muramatsu, Takaji Wakita, Tomoyoshi Nozaki, Hussein Hassan Aly	15
8	Activities of endogenous APOBEC3s and uracil-DNA-glycosylase affect the hypermutation frequency of hepatitis B virus cccDNA 2022 ·Journal of General Virology ·K Kitamura, Kento Fukano, (unknown), Yingfang Li, Kousho Wakae, Masamichi Muramatsu	3
9	Identification of natural compounds extracted from crude drugs as novel inhibitors of hepatitis C virus 2021 ·Biochemical and Biophysical Research Communications ·(unknown), Rui Guo, Qingbo Liu, Kousho Wakae, Noriyuki Watanabe, Kento Fukano, (unknown), Yingfang Li, Hussein Hassan Aly, Koichi Watashi, Ryosuke Suzuki, Asako Murayama, Takanobu Kato, Hideki Aizaki, Takaji Wakita, Xiao‐Xiao Huang, Yi Yan, Shao‐Jiang Song, Masamichi Muramatsu	5
10	MCPIP1 reduces HBV-RNA by targeting its epsilon structure 2020 ·Scientific Reports ·Yingfang Li, (unknown), Kento Fukano, Miki Koura, K Kitamura, Xin Zheng, Takanobu Kato, Hussein Hassan Aly, Koichi Watashi, Senko Tsukuda, Hideki Aizaki, Noriyuki Watanabe, Yuko Sato, Tadaki Suzuki, Hiroshi Suzuki, Kazuyoshi Hosomichi, Makoto Kurachi, Kousho Wakae, Masamichi Muramatsu	58
11	EBV‐LMP1 induces APOBEC3s and mitochondrial DNA hypermutation in nasopharyngeal cancer 2020 ·Cancer Medicine ·Kousho Wakae, Satoru Kondo, (unknown), Naohiro Wakisaka, (unknown), Yingfang Li, (unknown), Kento Fukano, K Kitamura, Koichi Watashi, Hideki Aizaki, Takayoshi Ueno, Makiko Moriyama‐Kita, Kazuya Ishikawa, Yosuke Nakanishi, Kazuhira Endo, Masamichi Muramatsu, Tomokazu Yoshizaki	13
12	Non-nucleoside hepatitis B virus polymerase inhibitors identified by an in vitro polymerase elongation assay 2019 ·Journal of Gastroenterology ·(unknown), Koichi Watashi, Kento Fukano, Senko Tsukuda, Kousho Wakae, Hideki Aizaki, Masamichi Muramatsu, Takaji Wakita, Tetsuya Toyoda	10
13	Troglitazone Impedes the Oligomerization of Sodium Taurocholate Cotransporting Polypeptide and Entry of Hepatitis B Virus Into Hepatocytes 2019 ·Frontiers in Microbiology ·Kento Fukano, Senko Tsukuda, (unknown), Ryosuke Suzuki, Hideki Aizaki, Mio Ohki, Sam‐Yong Park, Masamichi Muramatsu, Takaji Wakita, Camille Sureau, Yuki Ogasawara, Koichi Watashi	42
14	Concept of Viral Inhibitors via NTCP 2019 ·Seminars in Liver Disease ·Kento Fukano, Senko Tsukuda, Koichi Watashi, Takaji Wakita	24
15	A new strategy to identify hepatitis B virus entry inhibitors by AlphaScreen technology targeting the envelope-receptor interaction 2018 ·Biochemical and Biophysical Research Communications ·Wakana Saso, Senko Tsukuda, Hirofumi Ohashi, Kento Fukano, Ryo Morishita, Satoko Matsunaga, Mio Ohki, Akihide Ryo, Sam‐Yong Park, Ryosuke Suzuki, Hideki Aizaki, Masamichi Muramatsu, Camille Sureau, Takaji Wakita, Tetsuro Matano, Koichi Watashi	24
16	De Novo Macrocyclic Peptide Inhibitors of Hepatitis B Virus Cellular Entry 2018 ·Cell chemical biology ·Toby Passioura, Koichi Watashi, Kento Fukano, (unknown), Wakana Saso, Ryo Morishita, Yuki Ogasawara, Yasuhito Tanaka, Masashi Mizokami, Camille Sureau, Hiroaki Suga, Takaji Wakita	50
17	A Single Adaptive Mutation in Sodium Taurocholate Cotransporting Polypeptide Induced by Hepadnaviruses Determines Virus Species Specificity 2018 ·Journal of Virology ·Junko S. Takeuchi, Kento Fukano, Masashi Iwamoto, Senko Tsukuda, Ryosuke Suzuki, Hideki Aizaki, Masamichi Muramatsu, Takaji Wakita, Camille Sureau, Koichi Watashi	25
18	Development of a cell-based assay to identify hepatitis B virus entry inhibitors targeting the sodium taurocholate cotransporting polypeptide 2018 ·Oncotarget ·Kei Miyakawa, Satoko Matsunaga, Yutaro Yamaoka, (unknown), Kento Fukano, Hirokazu Kimura, (unknown), Hironori Nishitsuji, Koichi Watashi, Kunitada Shimotohno, Takaji Wakita, Akihide Ryo	19
19	Cyclosporin derivatives inhibit hepatitis B virus entry without interfering with NTCP transporter activity 2016 ·Journal of Hepatology ·(unknown), Koichi Watashi, Kento Fukano, Michael Peel, Ann E. Sluder, Fumihiro Kawai, Masashi Iwamoto, Senko Tsukuda, Junko S. Takeuchi, (unknown), Masaya Sugiyama, Yuki Ogasawara, Sam‐Yong Park, Yasuhito Tanaka, Hiroyuki Kusuhara, Masashi Mizokami, Camille Sureau, Takaji Wakita	94

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact